News | September 19, 2013

New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments

Kettering Medical Center is first in US to treat patient with Elekta's Versa HD radiation therapy system

elekta, elekta versa HD, radiation therapy

Elekta Versa HD

September 19, 2013 – On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD system to treat a patient, a 71-year-old woman with medically inoperable lung cancer.

The rapid speed of radiosurgery with Versa HD enabled Kettering physicians to reduce the number of treatment sessions for this patient from seven weeks to three days. In addition, each treatment session decreased from 40 minutes to less than 10 minutes.

"With Versa HD, we can cut total treatment times for our patients by at least three-to four-fold," says Douglas Einstein, M.D., Ph.D., Chairman of Radiation Oncology at Kettering Medical Center. "This new technology has the potential to allow us to add more patients to the daily radiotherapy schedule, including patients with long commutes because the number of sessions could radically decrease. Just as important, the decreased treatment time per session will improve the patient experience.

"For example, lung cancer patients who receive radiosurgery may have their arms raised for a 40-minute session and that can be difficult for some patients," he adds. "The High Dose Rate mode of Versa HD allows us to shorten radiation beam delivery time and improve patient comfort in radiosurgery cases."

To learn more about Versa HD, visit www.VersaHD.com

Versa HD is not available for sale or distribution in all markets.

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Elekta and Brainlab Offer Streamlined Workflow for Stereotactic Radiotherapy
News | Radiation Therapy | October 16, 2017
Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator...
Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.
Sponsored Content | Webinar | Radiation Therapy | October 13, 2017
The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" will be presented by Par
National Breast Center Founder Names Top Three Innovations in Breast Cancer Treatment
News | Women's Health | October 11, 2017
In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Image Guided Radiation Therapy (IGRT) | October 10, 2017
Elekta announced that members of the Elekta MR-linac Consortium reported data related to the advancement of the company...
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
David Beyer, M.D., chairman of the board for the American Society of Radiation Oncology (ASTRO), discusses the key th
Sponsored Content | Videos | Radiation Therapy | October 09, 2017
Benjamin Movsas, M.D., chair of the American Society for Radiation Oncology (ASTRO) Scientific Committee, explains ho
Overlay Init